Caranx Uses AI to Improve TAVI ProceduresCaranx Uses AI to Improve TAVI Procedures

The company has filed for FDA submission for TAVIPILOT Soft, a software that would provide real-time intra-operative guidance during TAVI procedures.

Omar Ford

January 27, 2025

1 Min Read
Heart cardiac surgery technology heart
Marcus Millo via iStock / Getty Images

One medtech company is combining the power of artificial intelligence with transcatheter aortic valve implantation (TAVI) procedures.

Caranx Medical said it filed for FDA submission for TAVIPILOT Soft, a software that would provide real-time intra-operative guidance for TAVI. The NICE, France-based company plans to introduce TAVIPILOT Soft by the end of the year.

“Allowing a broader number of cardiologists, surgeons and interventional cardiology centers to perform complex procedures, such as TAVI, the Caranx AI-driven software and autonomous robot is at the heart of our mission of entrepreneurs and business builders to save lives and revolutionize medicine” says Philippe Pouletty, MD, founder of Caranx and CEO of Truffle Capital.

TAVIPILOT Soft tracks real-time anatomical and instrument landmarks. It enables precise and accurate heart valve positioning and delivery. The company said TAVIPILOT Soft is expected to be a revolution for the transcatheter replacement of aortic valves, which is limited today because it is reserved for the most experienced cardiologists and centers. Caranax noted TAVIPILOT Soft is compatible with all cardiac Imaging Systems and will be compatible with principal TAVI heart valves on the market.

The TAVI space has become more competitive since the first procedure was performed 20 years ago. Most recently, Edwards Lifesciences announced one of the biggest acquisitions in the space. Irvine, CA-based company said it would acquire JenaValve.

Related:Cardiovascular Surgeon Aims to Make Type A Aortic Dissections Safer, Easier & More Affordable for Hospitals

Edwards also acquired JC Medical, which is the maker of the J-Valve System.  

About the Author

Omar Ford

Omar Ford is a veteran reporter in the field of medical technology and healthcare journalism. As Editor-in-Chief of MD+DI (Medical Device and Diagnostics Industry), a leading publication in the industry, Ford has established himself as an authoritative voice and a trusted source of information.

Ford, who has a bachelor's degree in print journalism from the University of South Carolina, has dedicated his career to reporting on the latest advancements and trends in the medical device and diagnostic sector.

During his tenure at MD+DI, Ford has covered a wide range of topics, including emerging medical technologies, regulatory developments, market trends, and the rise of artificial intelligence. He has interviewed influential leaders and key opinion leaders in the field, providing readers with valuable perspectives and expert analysis.

 

Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like